88 related articles for article (PubMed ID: 8833623)
61. [Interrelation of the level of acid phosphatase activity of erythrocytes and the phenotype of workers in the chemical industry].
Rafikov KhS; Khusnutdinova EK; Belova IIu
Gig Tr Prof Zabol; 1984 Jul; (7):18-22. PubMed ID: 6479666
[No Abstract] [Full Text] [Related]
62. [Reference rates for cohort studies in Italy: an essential tool in occupational and residential cohort studies].
Pirastu R; Ranucci A; Consonni D; De Santis M; Bruno C; Conti S; Fazzo L; Iavarone I; Pasetto R; Zona A; Magnani C; Comba P
Med Lav; 2016 Dec; 107(6):473-477. PubMed ID: 27976665
[TBL] [Abstract][Full Text] [Related]
63. Additional follow-up of cancer mortality among workers in a thermoelectric power plant.
Cammarano G; Crosignani P; Berrino H; Berra G
Scand J Work Environ Health; 1986 Dec; 12(6):631-2. PubMed ID: 3823815
[No Abstract] [Full Text] [Related]
64. Measuring occupational effects: how could we do it better?
Thun MJ
Epidemiology; 1991 Jan; 2(1):5-7. PubMed ID: 2021667
[No Abstract] [Full Text] [Related]
65. Re: Mortality of workers at a nuclear materials plant.
Mirer FE
Am J Ind Med; 1997 Jan; 31(1):121. PubMed ID: 8986265
[No Abstract] [Full Text] [Related]
66. Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials.
Girard I; Ferry S; Nony P; Boissel JP
Therapie; 1996; 51(2):191-2. PubMed ID: 8763055
[No Abstract] [Full Text] [Related]
67. An historical example of selective publication with contemporary implications: lead smelter workers and cancer.
Sullivan M
Int J Occup Environ Health; 2012; 18(2):124-9. PubMed ID: 22762492
[TBL] [Abstract][Full Text] [Related]
68. AN OCCUPATIONAL SYNDROME AMONG WORKERS IN ZINC.
McCord CP; Friedlander A
Am J Public Health (N Y); 1926 Mar; 16(3):274-80. PubMed ID: 18011782
[No Abstract] [Full Text] [Related]
69. Diseases Affecting Lead-Workers.
Holder W
Br Med J; 1876 Oct; 2(824):490-1. PubMed ID: 20748327
[No Abstract] [Full Text] [Related]
70. Treatment of Cancer by Lead.
Br Med J; 1926 Mar; 1(3401):431-4. PubMed ID: 20772422
[No Abstract] [Full Text] [Related]
71. The Pentose Phosphate Pathway as a Potential Target for Cancer Therapy.
Cho ES; Cha YH; Kim HS; Kim NH; Yook JI
Biomol Ther (Seoul); 2018 Jan; 26(1):29-38. PubMed ID: 29212304
[TBL] [Abstract][Full Text] [Related]
72. Glucose-6-phosphate dehydrogenase deficiency and risk of colorectal cancer in Northern Sardinia: A retrospective observational study.
Dore MP; Davoli A; Longo N; Marras G; Pes GM
Medicine (Baltimore); 2016 Nov; 95(44):e5254. PubMed ID: 27858887
[TBL] [Abstract][Full Text] [Related]
73. Causes of death among lead smelters in relation to the glucose-6-phosphate dehydrogenase polymorphism.
Cocco P; Fadda D; Atzeri S; Avataneo G; Meloni M; Flore C
Occup Environ Med; 2007 Jun; 64(6):414-6. PubMed ID: 17182638
[TBL] [Abstract][Full Text] [Related]
74. [Mortality from lung cancer among workers of a Sardinian lead smelter [Follow-up: 1972-2001]].
Carta P; Aru G; Cadeddu C; Nieddu V; Polizzi M; Nurchis P; Flore C; Salis S; Sanna Randaccio F
G Ital Med Lav Ergon; 2003; 25 Suppl(3):17-8. PubMed ID: 14979065
[TBL] [Abstract][Full Text] [Related]
75. [Patterns of mortality in a cohort of workers followed during 28 years: the Manresa study].
Puig T; Varas C; Pérez I; Abadal LT; Balaguer Vintró I
Rev Esp Cardiol; 2004 Oct; 57(10):924-30. PubMed ID: 15469789
[TBL] [Abstract][Full Text] [Related]
76. Occupational lead exposure and screening of glucose-6-phosphate dehydrogenase polymorphism: useful prevention or nonvoluntary discrimination?
Cocco P
Int Arch Occup Environ Health; 1998 Mar; 71(2):148-50. PubMed ID: 9553792
[TBL] [Abstract][Full Text] [Related]
77. [Morbidity among workers exposed to lead--review of epidemiological studies].
Hanke W; Szczenia-Dabrowska N
Med Pr; 1992; 43(4):321-8. PubMed ID: 1453949
[TBL] [Abstract][Full Text] [Related]
78. Mortality of lead smelter workers with the glucose-6-phosphate dehydrogenase-deficient phenotype.
Cocco P; Carta P; Flore C; Congia P; Manca MB; Saba G; Salis S
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):223-5. PubMed ID: 8833623
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
